BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• BioCapital

  New Blood Test Shows Promise In Cancer Fight, National Cancer Institute Study

  April 21, 2015

   · 

  1 min read
• 

  Deals

  Teva Finally Makes Mylan Bid Official, With $40 Billion Offer For Biggest Takeover in 2015

  April 21, 2015

   · 

  4 min read
• Smoking May Boost Mom’s Chances Of Having Twins, American Journal Of Human Biology

  April 21, 2015

   · 

  1 min read
• Genetown

  Decreased RBC Clearance Appears To Predict Development And Worsening Of Serious Diseases, Massachusetts General Hospital Study

  April 21, 2015

   · 

  5 min read
• 

  BioCapital

  Buy Vertex Now for $45B Or Risk It All, Analyst Tells Gilead

  April 21, 2015

   · 

  2 min read
• 

  Drug Development

  CAR-T Cell Companies Juno Therapeutics, Kite Pharma, and ZIOPHARM, Inc. Get Stock Jitters on Disappointing Novartis AG Trial News

  April 21, 2015

   · 

  2 min read
• 

  Genetown

  Cambridge’s Dimension Therapeutics Nabs $65 Million

  April 21, 2015

   · 

  2 min read
• 

  Policy

  In Largest Settlement Of Its Kind, Teva Will Pay $512 Million to Resolve Pay-to-Delay Case

  April 21, 2015

   · 

  2 min read
• 

  Business

  BREAKING: Perrigo Rejects $30B Mylan Bid, Says Deal “Substantially Undervalues” Irish Firm

  April 21, 2015

   · 

  4 min read
• Business

  Pain Therapeutics Resumes Responsibility For REMOXY

  April 21, 2015

   · 

  2 min read